579 related articles for article (PubMed ID: 10493494)
21. Integrative role of neuropeptides and cytokines in cancer anorexia-cachexia syndrome.
Patra SK; Arora S
Clin Chim Acta; 2012 Jul; 413(13-14):1025-34. PubMed ID: 22251421
[TBL] [Abstract][Full Text] [Related]
22. Recently identified peptides involved in the regulation of body weight.
Bessesen DH; Faggioni R
Semin Oncol; 1998 Apr; 25(2 Suppl 6):28-32. PubMed ID: 9625380
[TBL] [Abstract][Full Text] [Related]
23. Mode of leptin action in chicken hypothalamus.
Dridi S; Swennen Q; Decuypere E; Buyse J
Brain Res; 2005 Jun; 1047(2):214-23. PubMed ID: 15907812
[TBL] [Abstract][Full Text] [Related]
24. Waste management - cytokines, growth factors and cachexia.
Saini A; Al-Shanti N; Stewart CE
Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
[TBL] [Abstract][Full Text] [Related]
25. Neuropeptides and the control of food intake in fish.
Volkoff H; Canosa LF; Unniappan S; Cerdá-Reverter JM; Bernier NJ; Kelly SP; Peter RE
Gen Comp Endocrinol; 2005 May; 142(1-2):3-19. PubMed ID: 15862543
[TBL] [Abstract][Full Text] [Related]
26. Neural control of the anorexia-cachexia syndrome.
Laviano A; Inui A; Marks DL; Meguid MM; Pichard C; Rossi Fanelli F; Seelaender M
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1000-8. PubMed ID: 18713954
[TBL] [Abstract][Full Text] [Related]
27. Two important systems in energy homeostasis: melanocortins and melanin-concentrating hormone.
Tritos NA; Maratos-Flier E
Neuropeptides; 1999 Oct; 33(5):339-49. PubMed ID: 10657511
[TBL] [Abstract][Full Text] [Related]
28. Plasma and hypothalamic peptide-hormone levels regulating somatotroph function and energy balance in fed and fasted states: a comparative study in four strains of rats.
Kappeler L; Zizzari P; Grouselle D; Epelbaum J; Bluet-Pajot MT
J Neuroendocrinol; 2004 Dec; 16(12):980-8. PubMed ID: 15667453
[TBL] [Abstract][Full Text] [Related]
29. [The cachexia-anorexia syndrome among oncological patients].
Sosa-Sánchez R; Sánchez-Lara K; Motola-Kuba D; Green-Renner D
Gac Med Mex; 2008; 144(5):435-40. PubMed ID: 19043964
[TBL] [Abstract][Full Text] [Related]
30. Improving food intake in anorectic cancer patients.
Laviano A; Meguid MM; Rossi-Fanelli F
Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):421-6. PubMed ID: 12806216
[TBL] [Abstract][Full Text] [Related]
31. Cytokines in the pathogenesis of cancer cachexia.
Argilés JM; Busquets S; López-Soriano FJ
Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):401-6. PubMed ID: 12806213
[TBL] [Abstract][Full Text] [Related]
32. [Peptides are opening the door for novel treatments of obesity and loss of appetite].
Broberger C; Hökfelt T
Lakartidningen; 2002 Dec; 99(49):4982-9. PubMed ID: 12522988
[TBL] [Abstract][Full Text] [Related]
33. Interleukins and tumor necrosis factor as inhibitors of food intake.
Langhans W; Hrupka B
Neuropeptides; 1999 Oct; 33(5):415-24. PubMed ID: 10657519
[TBL] [Abstract][Full Text] [Related]
34. Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future.
Argilés JM; Busquets S; García-Martínez C; López-Soriano FJ
Nutrition; 2005 Sep; 21(9):977-85. PubMed ID: 16043325
[TBL] [Abstract][Full Text] [Related]
35. Hormonal, hypothalamic and striatal responses to reduced body weight gain are attenuated in anorectic rats bearing small tumors.
Pourtau L; Leemburg S; Roux P; Leste-Lasserre T; Costaglioli P; Garbay B; Drutel G; Konsman JP
Brain Behav Immun; 2011 May; 25(4):777-86. PubMed ID: 21334429
[TBL] [Abstract][Full Text] [Related]
36. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome.
Plata-Salamán CR
Nutrition; 2000 Oct; 16(10):1009-12. PubMed ID: 11054608
[TBL] [Abstract][Full Text] [Related]
37. Similar changes of hypothalamic feeding-regulating peptides mRNAs and plasma leptin levels in PTHrP-, LIF-secreting tumors-induced cachectic rats and adjuvant arthritic rats.
Suzuki H; Hashimoto H; Kawasaki M; Watanabe M; Otsubo H; Ishikura T; Fujihara H; Ohnishi H; Onuma E; Yamada-Okabe H; Takuwa Y; Ogata E; Nakamura T; Ueta Y
Int J Cancer; 2011 May; 128(9):2215-23. PubMed ID: 20602340
[TBL] [Abstract][Full Text] [Related]
38. Current perspectives of catabolic mediators of cancer cachexia.
Lelbach A; Muzes G; Feher J
Med Sci Monit; 2007 Sep; 13(9):RA168-173. PubMed ID: 17767131
[TBL] [Abstract][Full Text] [Related]
39. Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients.
Fortunati N; Manti R; Birocco N; Pugliese M; Brignardello E; Ciuffreda L; Catalano MG; Aragno M; Boccuzzi G
Oncol Rep; 2007 Dec; 18(6):1521-7. PubMed ID: 17982639
[TBL] [Abstract][Full Text] [Related]
40. Response of hypothalamic NPY mRNAs to a negative energy balance is less sensitive in cachectic mice bearing human tumor cells.
Nara-ashizawa N; Tsukada T; Maruyama K; Akiyama Y; Kajimura N; Yamaguchi K
Nutr Cancer; 2001; 41(1-2):111-8. PubMed ID: 12094613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
